A 12-week, facilitator-led shared decision-making (SDM) intervention was associated with a greater proportion of patients with asthma reporting equal treatment-related decision making with their provider compared with practices engaged in a traditional lunch-and-learn SDM approach, according to a study published in the Journal of Asthma.

Researchers randomly assigned 30 primary care practices across North Carolina that had ≥75 Medicaid patients with asthma who were >2 years old to a facilitator-led approach to implementing SDM (n=10), a 1-hour lunch-and-learn SDM training session (n=10), or a control group with no active intervention (n=10). A facilitator-led SDM intervention was a 12-week program led by trained facilitators from the research team who provided 1-hour-long sessions at the practice, with the goal of tailoring SDM to the practice’s culture.

The lunch-and-learn sessions involved 1-hour presentations each year for >2 years that discussed a general overview of the SDM toolkit for the care of patients with asthma. In the facilitator-led and traditional lunch-and-learn sessions, the primary outcome of interest was the perceptions of SDM, as assessed by questionnaire. Asthma-related emergency department visits, hospitalizations, and/or oral steroid prescription orders were collected as secondary outcomes.

A total of 705 and 523 surveys were collected from facilitator-led sites and lunch-and-learn sites, respectively. Facilitator-led sites had a higher percentage of patients who reported equal participation with their provider in making treatment decisions vs the lunch-and-learn sites (74.9% vs 66.3%, respectively; P =.001). No difference was found between the facilitator-led vs lunch-and-learn sites compared with controls in terms of emergency department visits (odds ratio [OR], 0.77 [95% CI, 0.57-1.04] vs OR, 0.83 [95% CI, 0.66-1.07]), number of hospitalizations (OR, 1.30 [95% CI, 0.59-2.89] vs OR, 1.40 [95% CI, 0.68-3.06]), or oral steroids (OR, 0.95 [95% CI, 0.79-1.15] vs OR, 1.03 [95% CI, 0.81-1.06]).

Limitations of the study include the lack of data on patients’ existing medications prescribed and the reliance on self-reports for the primary outcome, as well as data from only Medicaid patients.

Related Articles

Results of this small study “offer support for the use of structured approaches such as facilitator-led dissemination of complex interventions into primary care practices.”

Reference

Ludden T, Shade L, Reeves K, et al. Asthma dissemination around patient-centered treatments in North Carolina (ADAPT-NC): a cluster randomized control trial evaluating dissemination of an evidence-based shared decision-making intervention for asthma management [published online September 25, 2018]. J Asthma. doi:10.1080/02770903.2018.1514630

This article originally appeared on Pulmonology Advisor